BeStock  

SBC Medical Group SBC

US equityMarket cap rank #3681Consulting Services
$5.34 +$0.01 (+0.19%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $5.34 0.00%
Open$5.34
Prev close$5.33
Day range$5.28 – $5.45
Volume190.9K
Market cap$549.20M
P/E (TTM)11.1
Dividend yield–

Earnings

Average move on report day±5.2%last 6 reports
Closed higher1 of 617% of the time
Best reaction+4.2%
Worst reaction-12.5%

Stock move on the day after each report

-12.5%2024/Q4-5.0%2025/Q2-1.5%2025/Q3+4.2%2025/Q4-7.7%2026/Q1-0.3%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q213 Aug 2026Pre Market–-0.31%–
2026/Q114 May 2026Pre Market–-7.74%–
2025/Q427 Mar 2026Pre Market–+4.21%–
2025/Q314 Nov 2025Pre Market–-1.49%–
2025/Q213 Aug 2025Pre Market–-4.96%–
2024/Q428 Mar 2025Pre Market–-12.53%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • SBC Core Segment$44.68M 82.1%
  • Waqoo Segment$9.74M 17.9%

Latest reported quarter: Q2, ended Jun 2026

Revenue$49.19M+13.4% YoY
Operating profit$18.96M+30.3% YoY
Net profit$11.16M+357.5% YoY
Diluted EPS$0.10+400.0% YoY
Free cash flow$22.04M+349.1% YoY
Operating cash flow$22.51M

Revenue, last 8 quarters

$53.1MSep '24$44.4MDec '24$47.3MMar '25$43.4MJun '25$43.4MSep '25$39.6MDec '25$43.1MMar '26$49.2MJun '26

Net profit, last 8 quarters

$2.8MSep '24$6.5MDec '24$21.5MMar '25$2.4MJun '25$12.8MSep '25$14.3MDec '25$11.3MMar '26$11.2MJun '26

Profitability & balance sheet

Gross margin71.9%
Operating margin37.3%
Net margin28.0%
Return on equity19.3%
Return on assets13.6%
Return on invested capital17.2%
Current ratio3.31
Liabilities / assets31.2%
Cash & investments$184.62M
Total debt$42.73M
Net cash (debt)$141.89M
Free cash flow / sales34.5%

Discussion

No comments yet — be the first to weigh in on SBC.

Leave a comment

Scroll to Top